Intimate partner violence against women and under-five mortality: A systematic review and meta-Analysis (24138)
Background: Intimate partner violence (IPV) against women is a persistent global public health concern with lasting impacts on the health of affected women and their children. Although previous studies suggest a potential link between IPV and under-five mortality (U5M), the evidence remains inconclusive.
Methods: Seven databases (MEDLINE, EMBASE, Global Health, PsycINFO, Scopus, Web of Science, and CINAHL) were searched from inception to April 22, 2026. Studies were included if they examined the association between forms of IPV (any IPV or subtypes such as physical, sexual, emotional violence, or partner control behaviour) and under-five, infant and neonatal mortality. Two reviewers independently conducted study selection. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guideline was followed. Risk of bias was assessed using the Risk of Bias in Non-randomised Studies of Exposures (ROBINS-E) tool. Random-effects meta-analyses were conducted to estimate pooled odds ratios (ORs) and 95% confidence intervals (CIs).
Results: Twenty-eight studies comprising 684,004 participants were included in the review, of which 25 were included in the meta-analyses. IPV was associated with higher odds of U5M (OR 1.10; 95% CI 1.05–1.16), infant mortality (OR 1.32; 95% CI 1.11–1.57), and neonatal mortality (OR 1.36; 95% CI 1.19–1.55). Physical IPV (OR 1.37; 95% CI 1.17–1.61), sexual IPV (OR 1.70; 95% CI 1.33–2.17), and emotional IPV (OR 1.29; 95% CI 1.07–1.56) were associated with higher odds of neonatal mortality. Physical IPV was also associated with higher odds of infant mortality (OR 1.20; 95% CI 1.01–1.44). No statistically significant associations were observed between IPV subtypes and U5M.
Conclusions: IPV against women was associated with higher odds of under-five, infant, and neonatal mortality. These findings highlight the importance of addressing IPV within child health strategies, including strengthening legal protections, expanding survivor support systems, and integrating IPV detection and response into maternal and child health services.